Unknown

Dataset Information

0

Exploring the Science behind Bifidobacterium breve M-16V in Infant Health.


ABSTRACT: Probiotics intervention has been proposed as a feasible preventative approach against adverse health-related complications in infants. Nevertheless, the umbrella concept of probiotics has led to a massive application of probiotics in a range of products for promoting infant health, for which the strain-specificity, safety and efficacy findings associated with a specific probiotics strain are not clearly defined. Bifidobacterium breve M-16V is a commonly used probiotic strain in infants. M-16V has been demonstrated to offer potential in protecting infants from developing the devastating necrotising enterocolitis (NEC) and allergic diseases. This review comprehends the potential beneficial effects of M-16V on infant health particularly in the prevention and treatment of premature birth complications and immune-mediated disorders in infants. Mechanistic studies supporting the use of M-16V implicated that M-16V is capable of promoting early gut microbial colonisation and may be involved in the regulation of immune balance and inflammatory response to protect high-risk infants from NEC and allergies. Summarised information on M-16V has provided conceptual proof of the use of M-16V as a potential probiotics candidate aimed at promoting infant health, particularly in the vulnerable preterm population.

SUBMITTER: Wong CB 

PROVIDER: S-EPMC6723912 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5098803 | biostudies-literature
| S-EPMC4879462 | biostudies-literature
| S-EPMC3940439 | biostudies-literature
| S-EPMC6349036 | biostudies-literature
| S-EPMC6004411 | biostudies-literature
| S-EPMC5341466 | biostudies-literature
| S-EPMC7485856 | biostudies-literature
| S-EPMC8058467 | biostudies-literature
| S-EPMC3811376 | biostudies-literature
| S-EPMC3067287 | biostudies-literature